Measuring Patient Engagement

Kongressthemen
Patient engagement is becoming increasingly embedded in the drug development process, driven by both internal and external stakeholders. Externally, progressively aware and proactive patients are demanding more involvement in decisions involving their treatment, and regulatory pressures from global regulatory agencies are mounting.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2094576-3?pid=4832

Speakers: Anthony Pisa, Patient Advocate, Independant, Beyza Klein, Global Patient Engagement Director, Patient Insights and Measurements, Novartis AG, and more

https://go.evvnt.com/2094576-2?pid=4832

Frau Lily Macintyre